Amit Hazan
Stock Analyst at Goldman Sachs
(2.10)
# 2,967
Out of 5,152 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $62.46 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $9.10 | -72.53% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.13 | +1,581.42% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $15.06 | -46.88% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $64.70 | -2.63% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $169.94 | +60.06% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $17.60 | -3.41% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $3.44 | +12,563.76% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $25.35 | +73.57% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $83.89 | -12.98% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $18.60 | +184.95% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $24.32 | +134.38% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $12.57 | -24.42% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $111.04 | -6.34% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $21.64 | +177.26% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $93.01 | +23.64% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $370.50 | -59.51% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $72.99 | -36.98% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $496.70 | -51.34% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $93.45 | +89.41% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $239.63 | -38.66% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.51 | +669.53% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $62.46
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $9.10
Upside: -72.53%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.13
Upside: +1,581.42%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $15.06
Upside: -46.88%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $64.70
Upside: -2.63%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $169.94
Upside: +60.06%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $17.60
Upside: -3.41%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $3.44
Upside: +12,563.76%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $25.35
Upside: +73.57%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $83.89
Upside: -12.98%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $18.60
Upside: +184.95%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $24.32
Upside: +134.38%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $12.57
Upside: -24.42%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $111.04
Upside: -6.34%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $21.64
Upside: +177.26%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $93.01
Upside: +23.64%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $370.50
Upside: -59.51%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $72.99
Upside: -36.98%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $496.70
Upside: -51.34%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $93.45
Upside: +89.41%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $239.63
Upside: -38.66%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.51
Upside: +669.53%